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mTORC1 controls long-term 
memory retrieval
Magdalena Pereyra1, Cynthia Katche1, Ana Belén de Landeta1 & Jorge H. Medina1,2
Understanding how stored information emerges is a main question in the neurobiology of memory 
that is now increasingly gaining attention. However, molecular events underlying this memory stage, 
including involvement of protein synthesis, are not well defined. Mammalian target of rapamycin 
complex 1 (mTORC1), a central regulator of protein synthesis, has been implicated in synaptic plasticity 
and is required for memory formation. Using inhibitory avoidance (IA), we evaluated the role of 
mTORC1 in memory retrieval. Infusion of a selective mTORC1 inhibitor, rapamycin, into the dorsal 
hippocampus 15 or 40 min but not 3 h before testing at 24 h reversibly disrupted memory expression 
even in animals that had already expressed IA memory. Emetine, a general protein synthesis inhibitor, 
provoked a similar impairment. mTORC1 inhibition did not interfere with short-term memory retrieval. 
When infused before test at 7 or 14 but not at 28 days after training, rapamycin impaired memory 
expression. mTORC1 blockade in retrosplenial cortex, another structure required for IA memory, also 
impaired memory retention. In addition, pretest intrahippocampal rapamycin infusion impaired object 
location memory retrieval. Our results support the idea that ongoing protein synthesis mediated by 
activation of mTORC1 pathway is necessary for long but not for short term memory.
The ability to recall past events is a major determinant of survival strategies in all species. Memory retrieval is the 
act of making stored information available for immediate use and is considered to be a complex and probably 
multistage process by which previously acquired information is reactivated from a latent state to a state that per-
mits its expression. Not always but in most cases it is also accompanied by a behavioral output in the animal that 
constitutes the experimental assessment of a given memory. Memories reactivation at the time of retrieval seems 
to be a rapid process since animals may retrieve as soon as they receive, usually without notice, the CS or other 
cues including US remindful stimuli, another related memory recall or an emotional context associated.
A body of evidence suggest that long-term memories (LTM) rely on functional and structural changes at 
synapses, as Ramón y Cajal had proposed more than a century ago1–3. Neurons and their synapses that are reac-
tivated when the animals are demanded to retrieve are believed to be those that have been changed through 
the molecular processes that underlie memory formation1,4. But in contrast to this initial stage, the information 
about the molecular mechanisms of memory retrieval is surprisingly scarce and fragmentary, despite its neces-
sity for utilizing learned information. Some neurotransmitters and their receptors including metabotropic and 
AMPA glutamate receptors are required for memory retrieval in the hippocampus and related structures, while 
β-adrenoreceptors and cholinergic muscarinic receptors have neuromodulatory action5–11. In addition, several 
protein kinases including ERK1/2, PI3K and PKA are necessary for retrieval of fear-motivated memories in the 
hippocampus9,10,12. Despite the fact that protein synthesis has been extensively reported as a key factor in mem-
ory consolidation and reconsolidation, its role on memory retrieval remains controversial. Experiments using 
anisomycin as a general protein synthesis inhibitor (PSI) yielded negative or conflicting results13–15. However, 
Nader and coworkers11 recently found that pretest intramygdala infusion of anisomycin or rapamycin (rapa), a 
specific mTORC1 inhibitor, impaired auditory fear memory retrieval. These findings suggest that ongoing protein 
synthesis induced by mTORC1 pathway is required in the amygdala to enable memory retrieval.
mTORC1 is a serine/threonine kinase complex that modulates cell proliferation and growth, metabolism, 
autophagy, and mRNA translation initiation16. In the brain it has a prime function in regulating synaptic plas-
ticity and memory formation, via the control of protein synthesis, including dendritic translation of synaptic 
proteins17–20.
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Therefore, to further investigate the role of mTORC1 in memory retrieval we determined whether mTORC1 is 
required for retrieval of an inhibitory avoidance (IA) task, a fear-motivated and hippocampus-dependent learning 
experience. We found that inhibition of hippocampal mTORC1 using infusions of rapa before test (TS) sessions at 
1, 7 or 14 days after training provoked a marked and reversible impairment of recent and remote IA LTM expres-
sion, but not when mTORC1 inhibition was performed before testing for short-term or for 28 days long-term 
memory. Inhibition of mTORC1 before LTM testing in the retrosplenial cortex, another brain region involved in 
IA LTM retrieval21, also resulted in transient impairment in memory expression. LTM expression of object loca-
tion (OL) was also affected by pretest inhibition of mTORC1.
Results
Pretest infusion of rapamycin or emetine impaired IA LTM retrieval. We chose to use IA training 
because it is acquired in a single and brief training session, which makes it ideal for investigating the neural and 
molecular events associated with memory retrieval without interference from previous expression of the learned 
behavior which occurs in multi-trial tasks22.
Confirming and extending recent findings in auditory fear memory retrieval using intraamygdala infusions 
of PSIs11, we found that intrahippocampal infusions (Fig. 1a) of two different types of PSI, emetine (eme) or 
rapa, 15 min before an IA TS session performed 24 h post training greatly impaired the expression of IA LTM 
(Fig. 1b, p < 0.01, rapa compared to vehicle (veh) rats, Newman-Keuls Comparison Test after one-way ANOVA, 
n = 5–6 and Fig. 1c, p < 0.05, eme compared to veh rats, Student’s t Test, n = 7–8). Similar impairments in mem-
ory retrieval were obtained with the infusion of the specific inhibitor of mTORC1, rapa, or the administration of 
Figure 1. Protein synthesis is required for inhibitory avoidance long term memory retrieval. (a) Schematic 
representation of rat brain section at three rostrocaudal planes (AP: −3.6; −3.8 and −4.16 mm from Bregma) 
showing the extent of area reached by the infusion in the dorsal hippocampus (CA1). The drawings were 
adapted from Paxinos and Watson48. (b) Intrahippocampal rapamycin (Rapa) infusion 15 min before test 
(TS) session carried out 24 h after training (TR) impairs inhibitory avoidance long term memory (IA-LTM) 
retrieval. **p < 0.01, vehicle (Veh) vs. Rapa group and Rapa vs. reTS, one-way ANOVA followed by Newman-
Keuls Comparison Test, n = 5-6. Data are expressed as mean ± SEM of TR or TS session step-down latency. (c) 
Intrahippocampal infusion of emetine (Eme) 15 min before TS also affects 24 h IA-LTM retrieval. *p < 0.05, 
Veh vs. Eme group, unpaired Student’s t Test, n = 6-7. Data are expressed as mean ± SEM of TR or TS session 
step-down latency. (d) Reversible blockade of an already expressed IA-LTM memory by intrahippocampal Rapa 
infusion 15 min before TS session 24 h after the first TS without any infusion. **p < 0.01, Veh vs. Rapa, 1°TS 
Veh vs. Rapa, and Rapa vs. reTS groups; ***p < 0.001, Rapa vs. 1°TS Rapa groups, one-way ANOVA followed 
by Newman-Keuls Test, n = 9-10. Data are expressed as mean ± SEM of TR or TS session step-down latency.
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eme, which is a general PSI. The deficit on memory retrieval caused by rapa was transient, because a subsequent 
TS session performed 5 h after the first one showed normal IA retention performance (Fig. 1b, dark gray bar). 
Moreover, this reversible blockade of memory retrieval by intrahippocampal rapa was also seen in trained rats 
that expressed IA memory at a 24 h TS and the inhibitor of mTORC1 was given 15 min before a second TS car-
ried out 48 h after training (Fig. 1d, p < 0.05, rapa vs. veh groups, one-way ANOVA followed by Newman-Keuls 
Comparison Test, n = 9–10). When infused outside the intended area in the dorsal hippocampus rapa did not 
affect retrieval. For instance, it did not impair retention performance when infused in the dorsal thalamic region 
(n = 3) or the hippocampal hilus region (n = 2) (data not shown). Taking together, these findings indicate that 
ongoing protein synthesis is required in the dorsal hippocampus to retrieve IA memory.
The effect of intrahippocampal rapa on IA LTM expression was also seen when the compound was infused 
40 min before subjecting the animals to a TS session carried out 24 h after training (Fig. 2, p < 0.05, rapa 40 min 
compared to veh group, Newman-Keuls Comparison Test after one-way ANOVA, n = 9 per group). However, 
administration of rapa into the dorsal hippocampus 3 h before the TS session provoked no impairment on mem-
ory retrieval (Fig. 2, p > 0.05, rapa3h vs. veh animals, Newman-Keuls Comparison Test after one-way ANOVA, 
n = 9 per group).
Rapamycin affected LTM, but not STM recall. We next determined whether the effect of rapa on mem-
ory expression depends on the age of LTM to be retrieved. As shown in Fig. 3b,c the inhibition of mTORC1 15 min 
before TS sessions at 7 or 14 days after training impaired IA LTM retention performance (Fig. 3b,c, p < 0.05, 
rapa 7d vs. veh groups and rapa 14d vs. veh groups, Newman-Keuls Comparison Test after one-way ANOVA, 
n = 11-12 and n = 6-7 respectively). In both cases, a retest carried out 5 h after TS restored retrieval (Fig. 3b,c, 
dark gray bars). At 28 days after IA training, some authors had reported that memory expression becomes mus-
cimol and CNQX-insensitive after pretest intrahippocampal infusions23,24, suggesting that IA memory might 
become hippocampus-independent. Consistent with these previous works, the intrahippocampal infusion of rapa 
15 min before 28 days TS provoked no alterations in memory retrieval (Fig. 3d, p > 0.05, rapa 28d vs. veh groups, 
Student’s t Test, n = 9 per group). Moreover, mTORC1 is not required for retrieval of short-term memory (STM), 
because the infusion of rapa into the dorsal hippocampus 15 min before a TS session performed 2 h after training 
did not alter IA memory retention (Fig. 3a, p > 0.05, Student’s t Test, n = 8–12).
Memories have been proposed to rely on endogenous and exogenous substances state-dependent process25,26. 
The aim of the next experiment was to determine whether the impairing effect of pretest rapa on memory 
retrieval could be attributable to a mismatch between the pharmacological state of the animal in which informa-
tion was acquired and the one in which it was recalled rather than a consequence of retrieval molecular process 
disruption27,28. Four groups of rats received two infusions of vehicle or rapa, one delivered immediately after 
training and the other 15 min before testing (veh-veh, veh-rapa, rapa-veh and rapa-rapa). A one-way ANOVA 
showed a significant effect of treatment (p < 0.01, F = 6.54). The main finding of this experiment is that rapa 
impaired memory when given after training or before testing as well as when delivered at both time points (Fig. 4, 
veh-veh differs from all the others groups, Newman-Keuls Comparison Test after one-way ANOVA), indicating 
that alterations in the internal state of the rat is not responsible for the effect of pretest mTORC1 inhibition on 
memory retrieval.
Several non-specific factors affecting sensory-motor and emotional processes can influence retention per-
formance of an IA task. For this reason, we tested whether bilateral rapa infusion into the dorsal hippocampus 
affects locomotor or exploratory activity. As shown in Fig. 5, rapa had no discernible effects on these parameters 
Figure 2. Dynamics of rapamycin effect. Rats were bilaterally infused with rapamycin (Rapa) or saline (Veh) 
into the hippocampus 3 h or 40 min before a test (TS) session carried out 24 h after training (TR). *p < 0.05, 
Veh vs. Rapa 40 min and Rapa −3 h vs. Rapa-40min groups; p > 0.05, Veh vs. Rapa groups, one-way ANOVA 
followed by Newman-Keuls Comparison Test, n = 9 per group. Data are expressed as mean ± SEM of TR or TS 
session step-down latency.
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in an open field (p > 0.05, Student’s t Test for both rearings and crossings of veh vs. rapa groups, n = 12 per group). 
Taking together with the experiment showing that pretest rapa did not affect STM retrieval (Fig. 3a), these results 
indicate that the impairing effect of rapa on LTM retention is not due to non-specific actions on stepping-down 
latency.
Pretest rapamycin infusion on other brain regions also impaired memory retrieval. Several 
brain regions are simultaneously involved in memory retrieval, inasmuch as the memories on which retrieval 
is based certainly are not confined to any single brain region29,30. Taking this into account, we next determined 
whether mTORC1 in the retrosplenial cortex (RSC), a region involved in consolidation and expression of IA 
training21, is required for memory retrieval. As shown in Fig. 6b, the pretest infusion of rapa into the anterior part 
of RSC (Fig. 6a) transiently blocked IA memory retrieval in a reversible way (Fig. 6b, p < 0.05, Newman-Keuls 
Comparison Test after one-way ANOVA).
Pretest rapamycin infusion impaired OL memory retrieval. OL memory is the ability to discriminate 
the familiar location of previously encountered objects31,32. We chose this OL memory in order to assess if the 
disruptive effect of rapa on IA memory can be replicated in anon aversive hippocampus-dependent task. Figure 7 
Figure 3. Rapamycin effect depends on the age of the memory retrieved. (a) Rapamycin (Rapa) was administered 
15 min before a test (TS) session carried out 2 h after training (TR). p > 0.05, Vehicle (Veh) vs. Rapa short term 
memory groups, unpaired Student’s t Test, n = 8–12. Data are expressed as mean ± SEM of TR or TS session 
step-down latency. In the next experiments, Rapa was administered 15 min before a TS session carried out (b) 7 
(*p < 0.05, Veh vs. Rapa 7d and Veh vs. reTS groups, one-way ANOVA followed by Newman-Keuls Comparison 
Test, n = 11-12), (c) 14 (*p < 0.05, Veh vs. Rapa 14d groups, one-way ANOVA followed by Newman-Keuls 
Comparison Test,n = 6-7) or, (d) 28 days after TR (*p > 0.05, Vehvs. Rapa 28 d groups, unpaired Student´s t test 
n = 9 per group). Data are expressed as mean ± SEM of TR or TS session step-down latency.
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shows that the discrimination index significantly decreased with intrahippocampal administration of rapa 30 min 
before TS session of the OL task (p < 0.05, veh vs. rapa group, Student’s t test, n = 7-8).
Discussion
The ability to recall past event is of great importance in determining our uniqueness as individuals. In this regard, 
retrieval is critical for memory: without its retrieval it is not possible to ensure we have a given memory. The main 
finding of the present study is that a general PSI, eme, and a selective inhibitor of mTORC1, rapa, infused into 
the dorsal hippocampus before IA testing greatly impaired memory retrieval. Given that rapa has less nonspecific 
effects than a general PSI like eme, we chose to use the specific inhibitor of mTORC1 to further characterize the 
Figure 4. Intrahippocampal infusion of rapamycin 15 minutes before test does not alter neuronal internal state 
of the animals. Rats were bilaterally infused with rapamycin (Rapa) or saline (Veh) into hippocampus CA1 at 
two different time points: immediately after training (TR) and 15 min before a test (TS) session carried out 24 h 
after the TR. **p < 0.01, for Veh-Veh vs. Veh-Rapa, Veh-Veh vs. Rapa-Veh and Veh-Veh vs. Rapa-Rapa groups, 
one-way ANOVA followed by Newman-Keuls Comparison Test; n = 7-8. Data are expressed as mean ± SEM of 
TR or TS session step-down latency at 24 h after TR.
Figure 5. Intrahippocampal infusion of rapamycin 15 minutes before test does not affect exploratory behavior. 
Number of rearings (left panel) and crossings (right panel) of animals that had received intrahippocampal infusion 
of rapamycin (Rapa) or vehicle (Veh) 15 min before a 5 min open field session. p > 0.05, Veh vs. Rapa groups, 
unpaired Student´s t test, n = 12 per group. Data are presented as mean ± SEM number of crossings or rearings.
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involvement of ongoing protein synthesis on memory retrieval processing. The amnesic effect of rapa is lim-
ited to LTM, and does not depend on a drug-induced change in the internal state of the animal. Interestingly, 
STM retrieval does not require mTORC1 activity. This result cannot be explained by alterations in locomotor or 
exploratory activity, since rapa had no discernible effect on locomotion and exploration in an open field. Also, 
intrahippocampal rapa administration impaired memory expression of a non-aversive OL memory. Together, 
these findings endorse the idea that regulation of translation by mTORC1 at the moment of retrieval is required 
for the expression of LTM.
Remarkably, at each time point tested, the effect of rapamycin infusion on memory retrieval was transient 
since a 5 h re-test showed full memory recovery. This finding supports the idea that the infusion of rapa into 
the dorsal hippocampus produced no functional or anatomical damage and, is consistent with the fact that rapa 
administration 3 h prior testing had no effect on memory recall, suggesting that rapa has a limited action after its 
in vivo infusion.
Our present findings extend those of Lopez et al.11 who demonstrated that anisomycin and rapa delivered 
into the amygdala before testing impaired the retrieval of an auditory fear-conditioning. Because the inhibition 
Figure 6. Retrosplenial cortex mTORC1 inactivation 15 minutes before test reversibly disrupts inhibitory avoidance 
long term memory retrieval. (a) Schematic representation of rat brain section at three rostrocaudal planes (AP: −3.6; 
−3.8 and −4.16 mm from Bregma) showing the extent of area reached by the infusion in the anterior retrosplenial 
cortex (RSC). The drawings were adapted from Paxinos and Watson48. (b) Rats were bilaterally infused with 
rapamycin (Rapa) or saline (Veh) into the RSC 15 min before a test (TS) session carried out 24 h after the training 
(TR). *p < 0.05, Veh vs. Rapa and reTS vs. Rapa groups; one-way ANOVA followed by Newman-Keuls Comparison 
Test, n = 5 per group. Data are expressed as mean ± SEM of TR or TS session step-down latency.
Figure 7. Rapamycin delivered into the hippocampus 30 minutes before test session disrupts object location long 
term memory retrieval. Rats were bilaterally infused with rapamycin (Rapa) or saline (Veh) into the hippocampus 
30 min before a test session carried out 24 h after the training in object location task. *p < 0.05, Veh vs. Rapa 
groups, unpaired Student’s t Test, n = 7-8. Data are expressed as mean ± SEM of the discrimination index.
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of mTORC1 in the RSC before testing also impaired IA memory retrieval (Fig. 6) and that rapa also affect OL 
memory retrieval (Fig. 7), we are tempted to suggest that the requirement of mTORC1 in memory retrieval is a 
general feature of memory recall in mammals.
In contrast to the amnesic effect of rapa when administered 15 min pretest at 1, 2, 7 or 14 days, mTORC1 in IA 
memory retrieval was not required when animals were tested 28 days after training, probably because IA memory 
trace is no longer in the dorsal hippocampus 4 weeks after IA training. Interestingly, this time point coincides 
with the period of time at which the hippocampus becomes totally insensitive to the impairing effect of pretest 
infusions of muscimol33 or CNQX23, an AMPA/Kainate glutamate receptor antagonist. Our present findings using 
rapa are also consistent with experiments showing that disruption of hippocampal function mostly hindered 
recent LTM without affecting remote LTM29,34,35 although other authors had reversibly abolished remote memory 
recall by a brief optogenetic inhibition of CA136.
STM recall is also not affected by pretest infusions of rapa into the dorsal hippocampus, suggesting that 
mTORC1 activity is not necessary for the retrieval of IA memory at short times after training. This finding par-
allels those showing that STM does not depend on new protein synthesis3,37. It is interesting to note here that 
several behavioral experiments in rodents indicate the requirement of mTORC1 in the formation, consolidation 
and reconsolidation of LTM, but not STM19,22,38,39.
Also, we have shown that the rapa effect can be extended to an OL memory task, since intrahippocampal 
infusion of rapa before TS session hindered OL memory retrieval as shown in Fig. 7. Considering our present 
findings, the effect of mTORC1 blockade on memory retrieval appears to be valence-independent and the role of 
mTORC1 pathway on this memory phase can be generalized to several forms of associative learning tasks.
What are the upstream regulators of the activity of mTORC1? Extracellular activators of the mTORC1 path-
way with relevance to memory retrieval include brain-derived neurotrophic factor (BDNF) and glutamate17,40,41. 
Dendritic mTORC1 is activated by glutamate action on NMDA receptors to control long term potentiation 
(LTP)42 and metabotropic glutamate receptors activation results in enhancing ERK and AKT-mTOR pathways 
controlling protein synthesis and long-term depression43,44. Intracellular activators of mTORC1 such as ERK 1/2 
and AKT have also important modulatory effects on retrieval of IA memory9.
A prevailing view tells us that retrieval involves the reconstruction of patterns of brain activity produced 
during initial learning. In other words, reactivation of distributed ensembles of neurons in different brain regions 
that were active during initial learning is necessary for the subsequent retrieval of the memory. If this is the case, 
how are the patterns of activity in the hippocampus generated and controlled during retrieval? Many years ago, 
it was suggested that all or part of the mechanisms occurring during encoding have to be reestablished at the 
moment of recall in order to successfully retrieve memory27,28. However, our findings using posttraining and/
or pretest administration of rapa (Fig. 4) did not support this idea. Later on, molecular pharmacological data 
showed that the biochemical changes underlying IA consolidation are in part similar to those of retrieval. Indeed, 
some types of glutamate receptors and the activity of PKA, PKC and MAPKs are necessary for both consolidation 
and retrieval, and the modulation by D1 dopamine receptors, β-adrenoceptors, 5HT1A receptors and choliner-
gic muscarinic receptors is similar in both cases7,8,45,46. But the nature and the timing of the role played by each 
signaling pathway in consolidation is different from that of retrieval9. In addition, other mechanisms crucial for 
encoding or consolidation of IA LTM like NMDA receptors and CaMKII are in general terms not necessary for 
memory retrieval.
Besides changes in the modulation of translation, brief inhibition of mTORC1 by rapa affects biological pro-
cesses such as ion homeostasis, regulation of membrane potential, regulation of secretion and synaptic vesicle 
trafficking47. These findings suggest that acute inhibition of mTORC1 may greatly impact synaptic function and 
as a consequence impairs memory retrieval.
In conclusion, we found that the activity of mTORC1 close in time to memory recall is required for the nor-
mal expression of aversive and non-aversive LTM in the rat. Together with the seminal work of Nader group in 
amygdala11, our findings open new lines of research regarding the molecular mechanisms underlying memory 
retrieval.
Materials and Methods
Subjects. Male adult Wistar rats weighting 200–250 g on arrival (Facultad de Ciencias Exactas y Naturales, 
University of Buenos Aires) were housed in groups of five per cage and kept with water and food ad libitum under 
a 12 light/dark cycle (lights on at 7 A.M.) at a constant temperature of 23 °C. Experiments took place during the 
light phase of the cycle. Animals were handled for 3 min for 3 consecutive days before the experiment to avoid 
emotional stress.
All the experimental protocols used for this study followed the guidelines of the National Institutes of Health 
Guide for Care and Use of Laboratory Animals and were approved by the Animal Care and Use Committees of 
the University of Buenos Aires (CICUAL).
Surgery. Rats were bilaterally implanted under deep ketamine/xylazine anesthesia (100 and 5 mg/kg, respec-
tively) with a 22-gauge guide cannulae aimed to the dorsal CA1 region of the hippocampus (AP - 3.9 mm, 
LL ± 3.0 mm, DV - 3.0 mm from Bregma) or to the retrosplenial cortex (AP - 3.9 mm, LL ± 0.5 mm, DV - 1.8 mm 
from Bregma). Coordinates were based on Paxinos and Watson Atlas48. Cannulae were fixed to skull with dental 
acrylic. At the end of the surgery, animals were injected with a single dose of meloxicam (0.2 mg/kg) as analgesic 
and gentamicin (2.5 mg/kg) as antibiotic. Behavioral procedures took place 5–7 days after surgery.
Inhibitory Avoidance Task. After recovery from surgery, IA was performed as described previously22. 
During training, rats were placed on a 5 cm high, 9 cm wide platform at left of a 47 × 25 × 30 cm opaque acrylic 
box whose floor was a grid made of a series of parallel 1 mm-caliber steel bars spaced 1 cm apart. As they stepped 
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down onto the grid they received a 3 s, 0.7 mA scrambled foot shock and the latency to step down with all four 
paws was measured. Rats were tested for retention 2 h, 24 h, 2, 7, 14 or 28 days after training, depending on the 
experiment. In the TS the procedures were similar except that the foot-shock was omitted and the time spent on 
the platform was evaluated for a maximum of 300 s. Typical IA 24 h step-down latency was 150 ± 30 s. In the case 
where the reversibility of the rapa effect was examined, animals were retested 5 h after the first TS.
Object Location Task. The OL task consisted of 3 days of 20 min habituation sessions in the absence of 
the objects, a 10 min TR and a 3 min TS. Before habituation, all rats were handled 2 min daily for 3 days. The 
experimental apparatus was a 60 cm wide × 40 cm long × 50 cm high acrylic box with a transparent frontal wall 
and hatched back wall, while laterals walls were white with different visual clues. On the TR day, the objects (two 
identical glass bottles) were located in the arena in two adjacent corners and animals were allowed to explore for 
10 min. During TS, performed 24 h after training, one of the objects was switched to a new position and explo-
ration time was recorded again. A rat was scored as exploring an object when it orientates its head towards the 
object with the nose within 1 cm of the object with behaviors including sniffing, touching and gnawing. Sitting on 
the object, looking up while resting against the object or any time where the rat simply propped the forepaws onto 
the object with the nose pointing away from it were not counted as exploration. Rats were excluded of the analysis 
if they explore one of the objects more than 65% of total objects-exploration time during TR. In both TR and TS, 
rats with total objects-exploration time lower than 10 s were excluded. The exploration time was measured using 
a hand stopwatch and results are expressed as a discrimination index: [Exploration time of new location (Tn) - 
Exploration time of familiar location (Tf)]/(Tn + Tf).
From rat to rat, the familiar or novel OL of the object in TS was counterbalanced. The box and the objects were 
thoroughly cleaned between trials.
Open Field Test. To evaluate locomotor activity animals were exposed to an open field. The OF arena con-
sisted in a square box of 50 × 50 × 39 cm, with black walls and floor, which was divided into nine quadrants by 
white stripes. Animals were left to explore for 5 min and the exploratory activity was measured as the number of 
crossings between squares and the number of rearings registered minute by minute.
Drug Infusion. For intracerebral infusions, 30-gauge needles connected to Hamilton syringes were used. For 
rapa, the volume infused was 0.5 µl/side and the infusion rate was 0.5 µl/min. For eme, the volume infused was 
1 µl/side and the infusion rate was 1 µl/min. Infusions were delivered through a needle extending 1 mm beyond 
the tip of the guide cannulae. Injectors were left in place for an additional min following infusion before they 
were removed carefully to minimize backflow. During the procedure the animals were slightly restrained with the 
hands, without provoking any evident stress. Drugs and doses were as follows: rapa (specific mTORC1 inhibitor) 
60 nM/side and eme (irreversible protein synthesis inhibitor)49 50 µg/side, both dissolved in saline. These doses 
were chosen based on previous findings22,41. Drugs were purchased from Sigma-Aldrich (USA).
Cannula placement. Cannula placement was verified after the end of the behavioral procedures by infusions 
of 0.5 µl of a solution of 4% methylene blue in saline. Animals were killed by decapitation 15 min later and his-
tological localization of cannula placement was performed, taking the extension of the dye as an indicator of the 
presumable diffusion of rapa. Infusions spread with a radius between 0.5 and 1.0 mm3 as described before21,22,50 
was similar to that found using 3H-muscimol or fluorescent muscimol51,52 and is in agreement with published 
data from our group53, in which rhodamine labeled alpha-bungarotoxin infusions match those observed in the 
schema of Fig. 1a. Infusions were found to be correct (i.e., within 1.5 mm3 of the intended site) in 94% of the 
animals. Only the behavioral data from animals with the cannula located in the intended site were included in 
the final analysis.
Data analyses. Statistical analysis and graphs of behavioral data were performed with unpaired Student’s 
t test when comparing two groups and one-way ANOVA Test followed by Newman-Keuls Comparison Test 
when comparing 3 or more groups using Graph Pad Prism 5® software (Graphpad, La Jolla, CA, USA). In all the 
cases, α level was set at 0.05. IA data in the bar graphs were expressed as mean ± SEM of training or test session 
step-down latency. In addition, training effect was always found significant; thus, for the sake of visual simplicity 
symbols showing significant differences between step-down latencies of training and testing were omitted.
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